Skip to main content

A Comprehensive Look at U.S. Cannabis Tax Revenue

 

Marijuana Tax Revenue In Legal States

A Comprehensive Look at U.S. Cannabis Tax Revenue

Here’s a comprehensive look at how much tax revenue U.S. states with legal marijuana markets are generating — collectively and by state — and a note on what states without legal recreational marijuana are potentially missing out on.

📊 Total Tax Revenue from Legal Marijuana in the U.S.

💰 Cumulative Revenue Since 2014 (Adult-Use Only):

States with legal adult-use marijuana have generated about $24.7 billion + in total state tax revenue from recreational sales since markets launched in 2014.

In 2024 alone, these states collectively brought in more than $4.4 billion — the highest annual total recorded so far.

This revenue comes from excise taxes, retail sales taxes, and other cannabis-specific levies imposed by states on licensed marijuana sales.

🗺️ 2023 State Tax Revenue Breakdown (Adult-Use Cannabis)

These figures are approximate totals for 2023 adult-use cannabis taxes collected by states with regulated markets:

State Cannabis Tax Revenue (2023)
California~$1,082,000,000
Illinois~$552,000,000
Michigan~$473,000,000
Washington~$532,000,000
Arizona~$257,000,000
Massachusetts~$263,000,000
Oregon~$148,000,000
Missouri~$105,000,000
Nevada~$178,000,000
Colorado~$256,000,000
Alaska~$28,000,000
Connecticut~$24,000,000
Maryland~$29,000,000
Maine~$35,000,000
Other states (e.g., NJ, NM, VT, RI) added millions more~tens of millions
Total for 2023 in legal adult-use states: ~$4.18 billion+.

📌 Top Contributors (Across All Years)

Across the lifetime of legal markets:

  • ✔ California leads all states by a large margin — generating billions in tax revenues to date.
  • ✔ Washington, Colorado, Illinois, Michigan, Massachusetts, Oregon, and Nevada have each contributed hundreds of millions to over a billion cumulatively.

For example, some analyses show:

  • California’s total cannabis tax revenue over time may exceed $6+ billion.
  • Washington and Colorado have each brought in several billion dollars in cumulative taxes.
  • Multiple other states have crossed the $1 billion mark or are close to it.

🧾 Where the Money Is Used

States typically allocate cannabis tax revenues to public goods such as:

  • Education and early literacy programs
  • Healthcare and Medicaid support
  • School construction and maintenance
  • Drug treatment and prevention programs
  • Roads and infrastructure
  • Reinvestment in communities disproportionately affected by past cannabis prohibition laws
  • …and more.

Some cities and states even fund experimental programs — e.g., basic income pilots in parts of New Mexico funded partly by cannabis taxes.

🚫 What States Without Legal Recreational Marijuana Are Missing

States that still prohibit adult-use cannabis (or don’t yet have regulated sales) do not collect this tax revenue, despite many having:

  • Active black markets where cannabis is sold untaxed
  • Residents traveling across borders to purchase cannabis legally
  • Lost economic activity that could have been taxed and regulated

For example:

Surveys and political commentary show states like Iowa debating legalization partly because neighboring states’ cannabis tax revenue draws consumers—and dollars—away.

So while there’s no exact nationwide figure for potential “lost revenue,” the fact that legal states are pulling in billions annually highlights a significant fiscal opportunity cost for prohibition states.

📌 Key Takeaways

  • ✅ Legal cannabis has become a meaningful revenue source for states.
    • Nearly $25 billion in total state tax revenue collected nationally.
    • Record tax collections each year as markets mature.
  • ✅ Annual revenues are substantial in big markets.
    • California, Illinois, Michigan, Washington, Colorado, and others each bring in hundreds of millions annually.
  • ✅ Prohibition states are missing out on this revenue.
    • They lose out on billions that could be raised and invested locally.
    • They also forgo regulation, which can reduce illicit markets and improve consumer safety.


Labels:

Comments

Post a Comment

People's Choice

A Thank You Letter To President Trump for Opening the Door to Cannabis Research

  Trump's Cannabis From Schedule I to Schedule III Move Dear President Trump, I want to extend a sincere and enthusiastic thank you for your leadership in considering and moving forward with the rescheduling of marijuana from a Schedule I to a Schedule III controlled substance — a step that has already begun to reshape the national conversation around cannabis, research, and medical science. Your public remarks acknowledging that many people want this reclassification because it “leads to tremendous amounts of research that can’t be done unless you reclassify” reflect a willingness to look beyond old stigmas and recognize the potential for science and medicine to understand cannabis more fully. This shift — which would acknowledge cannabis as a substance with accepted medical use and a lower potential for abuse relative to Schedule I drugs — marks one of the most significant federal policy considerations in decades. By opening the door to research, innovation, an...
Post a Comment
Read more

Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean

  Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean Schedule I vs Schedule III Under the U.S. Controlled Substances Act (CSA), drugs are classified into schedules based on their accepted medical use, potential for abuse, and risk of dependence. Two key schedules in this context are Schedule I and Schedule III: Schedule I : Drugs with no currently accepted medical use in the U.S., a high potential for abuse , and potentially severe psychological or physical dependence. Examples include heroin, LSD, and currently, marijuana (cannabis). Schedule III : Drugs with accepted medical use , moderate to low potential for physical and psychological dependence, and a lower abuse risk compared to Schedules I or II. Examples include ketamine, anabolic steroids, testosterone, and certain codeine combinations (like Tylenol with codeine). Rescheduling marijuana from Schedule I to Schedule III would formally recognize its medical benefits...
Post a Comment
Read more

Free the Green: A Letter to President Donald J. Trump

  🇺🇸 Free the Green: A Letter to President Donald J. Trump An Open Plea from the American People & the Cannabis Family Legalize It President Trump, It’s time to Free the Green — to remove marijuana from the federal Schedule I classification, where it has been trapped since the Nixon era. A Law Without a Vote Few Americans realize that marijuana’s placement as a Schedule I drug — supposedly with “no medical value and a high potential for abuse” — was never voted on by Congress . It was assigned there in 1970 under the Controlled Substances Act by executive direction, intended as a temporary classification until a scientific commission could study the plant and make recommendations. That commission, known as the Shafer Commission , did complete its work — and in 1972, it recommended that marijuana should not be criminalized and should be removed from Schedule I entirely. The findings were ignored. Politics won. Science lost. And for over fifty years, that mi...
Post a Comment
Read more

What Is Nerolidol?

  Because of its sedative qualities, nerolidol-rich strains are often favored for evening use or for relaxation. What Is Nerolidol? Nerolidol is a naturally occurring sesquiterpene found in many plants. It has a distinctive aroma described as woody, floral, and slightly citrusy, often reminiscent of fresh ginger, jasmine, or bark. This terpene is known for its calming, sedative qualities and is commonly used in perfumes, cosmetics, and traditional herbal medicines. Nerolidol in Cannabis In cannabis, nerolidol contributes a subtle, complex aroma that blends woodsy and floral notes. It’s less common than some other terpenes but plays an important role in the overall scent and effect profile of certain strains. Strains high in nerolidol tend to be: Woody and floral Earthy with a touch of citrus Smooth and mellow Nerolidol itself does not produce intoxication but interacts with cannabinoids like THC and CBD to shape the overall experience. Effects Commo...
Post a Comment
Read more

What Is α-Bisabolol?

  α-Bisabolol-rich cannabis products are often preferred by those seeking gentle relaxation or relief from irritation and inflammation. What Is α-Bisabolol? α-Bisabolol is a naturally occurring terpene alcohol — one of the aromatic compounds found in many plants. It is best known for its soft, floral aroma and its calming, soothing properties, often associated with chamomile . Outside of cannabis, α-Bisabolol is widely found in: German chamomile Candeia tree Various medicinal herbs Skincare and cosmetic formulations Its gentle, slightly sweet scent has long been associated with calming effects and skin-soothing benefits. α-Bisabolol in Cannabis In cannabis, α-Bisabolol is a less common but highly valued terpene. When present in noticeable amounts, it contributes a smooth, floral aroma that can soften harsher terpene profiles. Cannabis strains containing α-Bisabolol often have aromas described as: Floral and chamomile-like Lightly sweet ...
Post a Comment
Read more